We observed that lowering APOC3 in Ai-DKO mice leads to downregulation of the expression of lipogenic genes in the liver and partially reverses the hypertriglyceridemia, but it does not affect hyperglycemia or hyperinsulinemia. This evidence concerns the gene APOC3 and hyperinsulinism.